Skip to main content

Advertisement

SpringerLink
Log in

Pilot study of adjuvant chemotherapy with 3-week combination of S-1 and cisplatin for patients with stage II-IV (M0) gastric cancer

  • PHASE II STUDIES
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

Summary

Purpose The feasibility of a 3-week combination of S-1 and cisplatin as an adjuvant chemotherapy for patients with curatively resected gastric cancer was investigated. Experimental design Korean patients with stage II-IV (M0) gastric adenocarcinoma who underwent a gastrectomy with D2 lymph node resection were enrolled. The S-1 was administered orally at 80 mg/m2 divided into two daily doses for 14 days, while the cisplatin was administered at 60 mg/m2 intravenously over 2 h every 21 days. The patients received a maximum of six cycles. Results From January 2006 to July 2010, 74 patients were included in this study. The median patient age was 56 years (range, 22–71), and 51.4% (38/74) of the patients had a performance status of 0. The median number of chemotherapy cycles administered was 6 (range, 1–6). The median relative dose intensity was 86.4% for S-1 and 80.0% for cisplatin. With a median follow-up duration of 13.9 months, the median relapse-free survival (RFS) and overall survival (OS) have not yet been reached. Fifteen relapses (20.3%) were documented. Plus, the estimated RFS rate was 60.5% at 3 years. The treatments were generally well tolerated. The most frequently observed grade 3–4 hematological toxicity was neutropenia (35.1%), and only 1 cycle of neutropenic fever occurred. The most frequently observed grade 3–4 non-hematological toxicities were nausea (4.1%) and asthenia (4.1%), and all the other grade 3–4 non-hematological toxicities were observed in less than 3% of the patients. Conclusions Postoperative adjuvant S-1 plus cisplatin for 18 weeks was found to be feasible for patients with stage II-IV (M0) gastric adenocarcinoma following complete surgical resection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Oba K (2009) Efficacy of adjuvant chemotherapy using tegafur-based regimen for curatively resected gastric cancer: update of a meta-analysis. Int J Clin Oncol 14:85–89

    Article  CAS  PubMed  Google Scholar 

  2. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, Haller DG, Ajani JA, Gunderson LL, Jessup JM, Martenson JA (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725–730

    Article  CAS  PubMed  Google Scholar 

  3. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ, MAGIC Trial Participants (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11–20

    Google Scholar 

  4. Kubota T (2008) The role of S-1 in the treatment of gastric cancer. Br J Canc 98:1301–1304

    Article  CAS  Google Scholar 

  5. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A, Arai K (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357:1810–1820

    Google Scholar 

  6. Koizumi W, Narahara H, Hara TT, Takagane A, Akiya T, Takagi M, Miyashita K, Nishizaki T, Kobayashi O, Takiyama W, Toh Y, Nagaie T, Takagi S, Yamamura Y, Yanaoka K, Orita H, Takeuchi M (2008) S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 9:215–221

    Google Scholar 

  7. Kodera Y, Ishiyama A, Yoshikawa T, Kinoshita T, Ito S, Yokoyama H, Mochizuki Y, Ito H, Tsuburaya A, Sakamoto J, Nakao A (2010) A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for gastric carcinoma (CCOG0703). Gastric Canc 13:197–203

    Google Scholar 

  8. Lee JL, Kang HJ, Kang YK, Ryu MH, Chang HM, Kim TW, Sohn HJ, Kim H, Lee JS (2008) Phase I/II study of 3-week combination of S-1 and cisplatin chemotherapy for metastatic or recurrent gastric cancer. Canc Chemother Pharmacol 61:837–845

    Article  CAS  Google Scholar 

  9. Takahari D, Hamaguchi T, Yoshimura K, Katai H, Ito S, Fuse N, Kinoshita T, Yasui H, Terashima M, Goto M, Tanigawa N, Shirao K, Sano T, Sasako M (2010) Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer. Canc Chemother Pharmacol

  10. Greene FL (2003) TNM staging for malignancies of the digestive tract: 2003 changes and beyond. Semin Surg Oncol 21:23–29

    Article  PubMed  Google Scholar 

  11. Saif MW, Syrigos KN, Katirtzoglou NA (2009) S-1: a promising new oral fluoropyrimidine derivative. Expet Opin Investig Drugs 18:335–348

    Article  CAS  Google Scholar 

  12. Hejna M, Wohrer S, Schmidinger M, Raderer M (2006) Postoperative chemotherapy for gastric cancer. Oncologist 11:136–145

    Article  CAS  PubMed  Google Scholar 

  13. Shirasaka T, Shimamoto Y, Ohshimo H, Saito H, Fukushima M (1993) Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo. Canc Chemother Pharmacol 32:167–172

    Article  CAS  Google Scholar 

  14. De Vita F, Giuliani F, Galizia G, Belli C, Aurilio G, Santabarbara G, Ciardiello F, Catalano G, Orditura M (2007) Neo-adjuvant and adjuvant chemotherapy of gastric cancer. Ann Oncol 18 Suppl 6:vi120–vi123

    Article  PubMed  Google Scholar 

  15. De Vita F, Vecchione L, Galizia G, Di Martino N, Fabozzi T, Catalano G, Ciardiello F, Orditura M (2009) Perspectives in adjuvant therapy of gastric cancer. Oncology 77 Suppl 1:38–42

    Article  PubMed  Google Scholar 

  16. Lee SS, Jeung HC, Chung HC, Noh SH, Hyung WJ, Ahn JY, Rha SY (2010) A pilot study of S-1 plus cisplatin versus 5-fluorouracil plus cisplatin for postoperative chemotherapy in histological stage IIIB-IV (M0) gastric cancer. Investig New Drugs

  17. Koizumi W, Tanabe S, Saigenji K, Ohtsu A, Boku N, Nagashima F, Shirao K, Matsumura Y, Gotoh M (2003) Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer. Br J Canc 89:2207–2212

    Article  CAS  Google Scholar 

Download references

Acknowledgments

All the authors collected the data, interpreted the data, and contributed to the manuscript in collaboration. The authors also reported no potential conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Hematology/Oncology, Kyungpook National University Hospital, Kyungpook National University School of Medicine, 200 Dongduk-Ro, Jung-Gu, Daegu, Korea, 700-712

    Byung Woog Kang, Jong Gwang Kim, Yee Soo Chae, Yoo Jin Lee, Soo Jung Lee, Joon Ho Moon & Sang Kyun Sohn

  2. Department of Gastroenterology, Kyungpook National University Hospital, Kyungpook National University School of Medicine, Daegu, South Korea

    Min Kyu Jung & Seong Woo Jeon

  3. Department of Radiology, Kyungpook National University Hospital, Kyungpook National University School of Medicine, Daegu, South Korea

    Yun-Jin Jang

  4. Department of Surgery, Kyungpook National University Hospital, Kyungpook National University School of Medicine, 200 Dongduk-Ro, Jung-Gu, Daegu, Korea, 700-712

    Jongduk Seo, Yong Hyun Lee, Ohkyung Kwon, Ho Young Chung & Wansik Yu

Authors
  1. Byung Woog Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jong Gwang Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yee Soo Chae
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yoo Jin Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Soo Jung Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Joon Ho Moon
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sang Kyun Sohn
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Min Kyu Jung
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Seong Woo Jeon
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yun-Jin Jang
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Jongduk Seo
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Yong Hyun Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Ohkyung Kwon
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Ho Young Chung
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Wansik Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Jong Gwang Kim or Wansik Yu.

Additional information

Jong Gwang Kim and Wansik Yu contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kang, B.W., Kim, J.G., Chae, Y.S. et al. Pilot study of adjuvant chemotherapy with 3-week combination of S-1 and cisplatin for patients with stage II-IV (M0) gastric cancer. Invest New Drugs 30, 1671–1675 (2012). https://doi.org/10.1007/s10637-011-9729-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10637-011-9729-y

Keywords

Search

Navigation